Syntax Bio Expands Series A to $14.4 Million, Strengthens Leadership Team and Advances Cell Programming Platform for Type 1 Diabetes Therapies Syntax Bio, a synthetic biology company focused on programming…
WISE Raises €30 Million in Oversubscribed Series D Round to Advance Heron Spinal Cord Stimulation Lead and Expand Neurotechnology Platform WISE S.p.A., an Italian medical device company developing advanced implantable…
101 Therapeutics Publicly Releases Clinical and Scientific Data for Macrophage-Targeted Anti-Inflammatory Candidate as It Seeks Urgent Review for Bundibugyo Ebola Outbreak Use 101 Therapeutics Ltd. has publicly released a broad…
Incyte Japan Secures Approval for Minjuvi Combo in Relapsed or Refractory DLBCL Incyte Biosciences Japan G.K. has secured a significant regulatory milestone in Japan with the approval of Minjuvi® (tafasitamab)…
Align Technology Names Kevin Conroy Board Chairman as Longtime Chair Ray Larkin Begins Leadership Transition Align Technology, Inc., the global medical device company best known for its Invisalign clear aligner…
Astrogen Wins International Psychiatry Honor for Autism Clinical Trial Research, Strengthening Momentum for Speragen’s Global Development Astrogen, Inc., a South Korean biotechnology company focused on developing therapies for neurodevelopmental disorders,…
Imperative Care Reports New SYMPHONY-PE Analysis Highlighting Potential Benefits of Early Thrombectomy as Symphony Use Surpasses 500 U.S. Patients Imperative Care, a medical technology company focused on improving treatment options…
bioAffinity Technologies Closes $3.2 Million Public Offering to Support Growth in Lung Disease Diagnostics bioAffinity Technologies, Inc., a biotechnology company focused on developing noninvasive diagnostic tools for the early detection…
Walgreens Expands July 4 Pharmacy Access and Holiday Services to Support Independence Day Needs Walgreens is preparing to play an important role for customers this Independence Day by combining holiday…
AngioDynamics Receives FDA Approval to Launch RELIEF Study Evaluating NanoKnife Technology for Benign Prostatic Hyperplasia AngioDynamics, Inc., a medical technology company focused on advancing innovative therapies that improve vascular health,…
Latin Clinical Trial Center Becomes Part of PhaseWell Research, Expanding Research and Therapeutic Access PhaseWell Research, a rapidly growing multisite clinical research organization dedicated to expanding access to clinical trials…
Oligomerix Receives $1.9 Million NIH Grant to Advance Oral Tau-Targeting Therapy for Alzheimer’s Disease Oligomerix, Inc., a privately held clinical-stage biotechnology company focused on developing novel treatments for Alzheimer’s disease…